Name: SRS22170294 - Non-tumor DNA sample from BLOOD/PLASMA of a human male participant in the dbGaP study "Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma"
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/home/about/policies/

SRS22170294 - Non-tumor DNA sample from BLOOD/PLASMA of a human male participant in the dbGaP study "Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma" | seqout